Publications

Search ACTG publications from 1/1/2006 to current.

Search

Filter results by

Found 7 results
Filters: First Letter Of Title is R and Author is Gulick, Roy M  [Clear All Filters]
Found 7 results.
Skip Alphabet Links A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

R

Ribaudo HJ, Smith KY, Robbins GK, et al. "Racial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis." Clin. Infect. Dis.. 2013;57(11):1607-17.
Schackman BR, Ribaudo HJ, Krambrink A, Hughes V, Kuritzkes DR, Gulick RM. "Racial differences in virologic failure associated with adherence and quality of life on efavirenz-containing regimens for initial HIV therapy: results of ACTG A5095." J. Acquir. Immune Defic. Syndr.. 2007;46(5):547-54.
Benson CA, Vaida F, Havlir DV, et al. "A randomized trial of treatment interruption before optimized antiretroviral therapy for persons with drug-resistant HIV: 48-week virologic results of ACTG A5086." J. Infect. Dis.. 2006;194(9):1309-18.
Wilkin TJ, Goetz MBidwell, Leduc R, et al. "Reanalysis of coreceptor tropism in HIV-1-infected adults using a phenotypic assay with enhanced sensitivity." Clin. Infect. Dis.. 2011;52(7):925-8.
Weinberg A, Bosch R, Bennett K, et al. "Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS." J. Acquir. Immune Defic. Syndr.. 2014;66(1):25-32.
Wilkin TJ, Ribaudo HR, Tenorio AR, Gulick RM. "The relationship of CCR5 antagonists to CD4+ T-cell gain: a meta-regression of recent clinical trials in treatment-experienced HIV-infected patients." HIV Clin Trials. 2010;11(6):351-8.
Su Z, Gulick RM, Krambrink A, et al. "Response to vicriviroc in treatment-experienced subjects, as determined by an enhanced-sensitivity coreceptor tropism assay: reanalysis of AIDS clinical trials group A5211." J. Infect. Dis.. 2009;200(11):1724-8.